A Trial Investigating the Pharmacokinetic Properties of NN1250 [insulin degludec] in Children, Adolescents and Adults With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 21 Apr 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2008-008306-43).
- 16 Sep 2011 Status changed from recruiting to completed, based on publication of results.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History